Acelyrin Inc.

NASDAQ: SLRN · Real-Time Price · USD
2.27
0.00 (0.00%)
At close: May 20, 2025, 3:59 PM

Acelyrin Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 115K n/a n/a
Gross Profit
n/a -115K n/a n/a
Operating Income
-316.26M -422.06M -254.68M -41.79M
Interest Income
31.21M 30.55M 4.17M n/a
Pretax Income
-248.23M -381.64M -250.46M -41.84M
Net Income
-248.23M -381.64M -250.46M -41.84M
Selling & General & Admin
66.81M 66.18M 24.05M 3.56M
Research & Development
238.06M 355.89M 230.63M 38.23M
Other Expenses
11.39M 3M -132K -45K
Operating Expenses
316.26M 422.06M 254.68M 41.79M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-304.86M 422.06M 254.68M 41.79M
Income Tax Expense
n/a n/a -4.17M -41.79K
Shares Outstanding (Basic)
99.3M 70.25M 20.44M 20.44M
Shares Outstanding (Diluted)
99.3M 70.25M 20.44M 20.44M
EPS (Basic)
-2.5 -5.43 -12.25 -2.05
EPS (Diluted)
-2.5 -5.43 -12.25 -2.05
EBITDA
-247.8M -381.53M -64.77M -41.84M
EBIT
-248.23M -381.64M -64.77M -41.84M
Depreciation & Amortization
423K 115K 69.18K 41.79K